These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 23599969)
1. [Is the approach to therapy of AL-amyloidosis changing--editorial]. Elbl L Vnitr Lek; 2013 Feb; 59(2):96-8. PubMed ID: 23599969 [No Abstract] [Full Text] [Related]
2. [Heart transplantation and the subsequent treatment of AL amyloidosis]. Adam Z; Krejčí J; Krejčí M; Němec P; Spinarová L; Zampachová V; Cermáková Z; Pika T; Pour L; Kořístek Z; Tomíška M; Szturz P; Král Z; Mayer J Vnitr Lek; 2013 Feb; 59(2):136-47. PubMed ID: 23461404 [TBL] [Abstract][Full Text] [Related]
3. [Three patients with primary AL amyloidosis treated by high-dose melphalan with autologous peripheral blood stem cell transplantation]. Mukai S; Kanashima H; Ogawa Y; Nakao T; Teshima H; Yamane T Gan To Kagaku Ryoho; 2012 Apr; 39(4):625-7. PubMed ID: 22504689 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of AL-amyloidosis in 2012, role of new drugs--editorial]. Tóthová E Vnitr Lek; 2013 Jan; 59(1):13-5. PubMed ID: 23565515 [No Abstract] [Full Text] [Related]
5. High-dose melphalan and autologous hematopoietic stem cell transplantation in primary amyloidosis: single-center results. Charlinski G; Ziarkiewicz M; Boguradzki P; Wiater E; Torosian T; Dwilewicz-Trojaczek J; Wiktor-Jedrzejczak W Transplant Proc; 2014 Oct; 46(8):2877-81. PubMed ID: 25380940 [TBL] [Abstract][Full Text] [Related]
6. Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis. Kristen AV; Sack FU; Schonland SO; Hegenbart U; Helmke BM; Koch A; Schnabel PA; Röcken C; Hardt S; Remppis A; Goldschmidt H; Karck M; Ho AD; Katus HA; Dengler TJ Eur J Heart Fail; 2009 Oct; 11(10):1014-20. PubMed ID: 19789405 [TBL] [Abstract][Full Text] [Related]
7. [Heart transplantation in AL amyloidosis]. Dahlberg P; Bartfay SE; Karason K; Mellqvist UH; Bollano E Lakartidningen; 2018 Mar; 115():. PubMed ID: 29583159 [TBL] [Abstract][Full Text] [Related]
8. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis. Meier-Ewert HK; Sanchorawala V; Berk J; Finn KT; Skinner M; Seldin DC; Ruberg FL Amyloid; 2011 Jun; 18 Suppl 1():130-1. PubMed ID: 21838460 [No Abstract] [Full Text] [Related]
9. [Clinical investigation of primary amyloidosis with autologous hematopoietic stem cell transplantation]. Qiu ZX; Wang MJ; Wang LH; Sun YH; Xu WL; Liu W; Ou JP; Dong YJ; Wang WS; Li Y; Yin Y; Liang ZY; Cen XN; Ren HY Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):187-90. PubMed ID: 22781604 [TBL] [Abstract][Full Text] [Related]
10. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis. Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532 [TBL] [Abstract][Full Text] [Related]
11. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis. Sanchorawala V; Seldin DC Amyloid; 2007 Dec; 14(4):261-9. PubMed ID: 17968685 [TBL] [Abstract][Full Text] [Related]
12. Transplantation vs. conventional-dose therapy for amyloidosis. Palladini G; Merlini G Curr Opin Oncol; 2011 Mar; 23(2):214-20. PubMed ID: 21178616 [TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation Is a Potential Treatment Option for Systemic Light Chain Amyloidosis Patients with Dominant Hepatic Involvement: A Case Report and Analytical Review of the Literature. Ueno A; Katoh N; Aramaki O; Makuuchi M; Ikeda S Intern Med; 2016; 55(12):1585-90. PubMed ID: 27301510 [TBL] [Abstract][Full Text] [Related]
14. Cardiac transplantation for amyloid heart disease: the United Kingdom experience. Dubrey SW; Burke MM; Hawkins PN; Banner NR J Heart Lung Transplant; 2004 Oct; 23(10):1142-53. PubMed ID: 15477107 [TBL] [Abstract][Full Text] [Related]
15. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients. Mignot A; Varnous S; Redonnet M; Jaccard A; Epailly E; Vermes E; Boissonnat P; Gandjbakhch I; Herpin D; Touchard G; Bridoux F Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment of renal light chain (AL) amyloidosis with bortezomib and dexamethasone (VD). Huang B; Li J; Xu X; Zheng D; Zhou Z; Liu J Pathol Biol (Paris); 2015 Feb; 63(1):17-20. PubMed ID: 25455933 [TBL] [Abstract][Full Text] [Related]
17. AL amyloidosis in a young adult: remission with autologous stem cell transplantation. Golmia RP; Bello IC; Rosseto E; Guerra JC; Mangueira C; Scheinberg MA Rev Bras Reumatol; 2010; 50(5):603-8. PubMed ID: 21125195 [TBL] [Abstract][Full Text] [Related]
19. A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis. Quillen K; Seldin DC; Finn KT; Sanchorawala V Bone Marrow Transplant; 2011 Jul; 46(7):976-80. PubMed ID: 20956955 [TBL] [Abstract][Full Text] [Related]
20. [Immunomodulatory drugs in the treatment of primary systemic light chain amyloidosis]. Charliński G; Wiater E; Jedrzejczak WW Pol Merkur Lekarski; 2012 Apr; 32(190):217-20. PubMed ID: 22708276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]